Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects. [electronic resource]
- Blood Nov 2006
- 2979-88 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't